I think that was a case where a chemist trade using confidential knowledge... not like a fund get insider knowledge and front run others. http://seekingalpha.com/article/261076-fda-insider-trading-time-for-an-overhaul Also, I don't see spike in put volume, in contrast, lots of call volume. If you know MNTA is going to follow, you buy tons of puts not selling calls.